Stroke Research Today is a free monthly online journal that collates and summarizes the latest research about Stroke, including details on treatment, recovery, rehabilitation, signs, symptoms.

Volume 5 (2008), Issue 6 (June)

1. Length of stay in in-patient rehabilitation after stroke in Qatar.
   ScientificWorldJournal, 8: 547-55. [Abstract] [Full-text]
2. GDNF fusion protein for targeted-drug delivery across the human blood-brain barrier.
   Biotechnol Bioeng, 100(2): 387-96. [Abstract] [Full-text]
3. Inhibition of GSK-3 reduces infarct volume and improves neurobehavioral functions.
   Biochem Biophys Res Commun, 371(4): 894-9. [Abstract] [Full-text]
4. Impact of socio-economic factors on stroke prevalence among urban and rural residents in Mainland China.
   BMC Public Health, 8: 170. [Abstract] [Full-text]
5. Anterior cerebral artery infarction: stroke mechanism and clinical-imaging study in 100 patients.
   Neurology, 70(24): 2386-93. [Abstract] [Full-text]
6. Normal head impulse test differentiates acute cerebellar strokes from vestibular neuritis.
   Neurology, 70(24): 2378-85. [Abstract] [Full-text]
7. Baseline NIH Stroke Scale Score predicting outcome in anterior and posterior circulation strokes.
   Neurology, 70(24): 2371-7. [Abstract] [Full-text]
8. Hemorrhagic stroke in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels study.
   Neurology, 70(24): 2364-70. [Abstract] [Full-text]
9. Ischemic stroke in patients with primary brain tumors.
   Neurology, 70(24): 2314-20. [Abstract] [Full-text]
10. Cyclooxygenase selectivity of nonsteroidal anti-inflammatory drugs and risk of stroke.
    Arch Intern Med, 168(11): 1219-24. [Abstract] [Full-text]
11. Effects of low-frequency repetitive transcranial magnetic stimulation of the contralesional primary motor cortex on movement kinematics and neural activity in subcortical stroke.
    Arch Neurol, 65(6): 741-7. [Abstract] [Full-text]
12. Early stroke risk after transient ischemic attack among individuals with symptomatic intracranial artery stenosis.
    Arch Neurol, 65(6): 733-7. [Abstract] [Full-text]
13. Anaortic techniques reduce neurological morbidity after off-pump coronary artery bypass surgery.
    Heart Lung Circ, 17(4): 299-304. [Abstract] [Full-text]
14. Surgery can reduce the nonoperative care associated with an equinovarus foot deformity.
    Clin Orthop Relat Res, 466(7): 1683-7. [Abstract] [Full-text]
15. A propensity-matched study of hypertension and increased stroke-related hospitalization in chronic heart failure.
    Am J Cardiol, 101(12): 1772-6. [Abstract] [Full-text]
16. Incidence of seizures in the acute phase of stroke: a population-based study.
    Epilepsia, 49(6): 974-81. [Abstract] [Full-text]
17. Longitudinal in vivo MRI of alterations in perilesional tissue after transient ischemic stroke in rats.
    Exp Neurol, 212(1): 207-12. [Abstract] [Full-text]
18. Upregulation of DSCR1 (RCAN1 or Adapt78) in the peri-infarct cortex after experimental stroke.
    Exp Neurol, 212(1): 85-92. [Abstract] [Full-text]
19. SB 234551 selective ET(A) receptor antagonism: perfusion/diffusion MRI used to define treatable stroke model, time to treatment and mechanism of protection.
    Exp Neurol, 212(1): 53-62. [Abstract] [Full-text]
20. Motor cortical stimulation promotes synaptic plasticity and behavioral improvements following sensorimotor cortex lesions.
    Exp Neurol, 212(1): 14-28. [Abstract] [Full-text]
21. Haplotypes of the fibrinogen gene and cerebral small vessel disease: the Rotterdam scan study.
    J Neurol Neurosurg Psychiatry, 79(7): 799-803. [Abstract] [Full-text]
22. Subtle neurological abnormalities as risk factors for cognitive and functional decline, cerebrovascular events, and mortality in older community-dwelling adults.
    Arch Intern Med, 168(12): 1270-6. [Abstract] [Full-text]
23. Nogo-A expression after focal ischemic stroke in the adult rat.
    Stroke, 39(7): 2091-8. [Abstract] [Full-text]
24. Overexpression of human S100B exacerbates brain damage and periinfarct gliosis after permanent focal ischemia.
    Stroke, 39(7): 2114-21. [Abstract] [Full-text]
25. Not all stroke units are the same: a comparison of physical activity patterns in Melbourne, Australia, and Trondheim, Norway.
    Stroke, 39(7): 2059-65. [Abstract] [Full-text]
26. Endothelial progenitor cell research in stroke: a potential shift in pathophysiological and therapeutical concepts.
    Stroke, 39(7): 2158-65. [Abstract] [Full-text]
27. Impact of comorbidities on ischemic stroke outcomes in women.
    Stroke, 39(7): 2138-40. [Abstract] [Full-text]
28. Reduction in the recurrence of stroke by eicosapentaenoic acid for hypercholesterolemic patients: subanalysis of the JELIS trial.
    Stroke, 39(7): 2052-8. [Abstract] [Full-text]
29. Pulse pressure and mean arterial pressure in relation to ischemic stroke among patients with uncontrolled hypertension in rural areas of China.
    Stroke, 39(7): 1932-7. [Abstract] [Full-text]
30. Reperfusion half-life: a novel pharmacodynamic measure of thrombolytic activity.
    Stroke, 39(7): 2148-50. [Abstract] [Full-text]
31. Depression as a risk factor for the incidence of first-ever stroke in 85-year-olds.
    Stroke, 39(7): 1960-5. [Abstract] [Full-text]
32. High serum levels of endothelin-1 predict severe cerebral edema in patients with acute ischemic stroke treated with t-PA.
    Stroke, 39(7): 2006-10. [Abstract] [Full-text]
33. Filamentous middle cerebral artery occlusion causes ischemic damage to the retina in mice.
    Stroke, 39(7): 2099-104. [Abstract] [Full-text]
34. Performance of comorbidity measures to predict stroke and death in a community-dwelling, hypertensive Medicaid population.
    Stroke, 39(7): 1938-44. [Abstract] [Full-text]
35. Influence of socioeconomic status and gender on stroke treatment and diagnostics.
    Stroke, 39(7): 2066-72. [Abstract] [Full-text]
36. Multimodal MRI in cerebral small vessel disease: its relationship with cognition and sensitivity to change over time.
    Stroke, 39(7): 1999-2005. [Abstract] [Full-text]
37. Biomarkers of Inflammation and MRI-Defined Small Vessel Disease of the Brain: The Cardiovascular Health Study.
    Stroke, 39(7): 1952-9. [Abstract] [Full-text]
38. Nonaspirin NSAIDs, cyclooxygenase 2 inhibitors, and the risk for stroke.
    Stroke, 39(7): 2037-45. [Abstract] [Full-text]
39. Trends in incidence, risk factors, and survival in symptomatic lacunar stroke in Dijon, France, from 1989 to 2006: a population-based study.
    Stroke, 39(7): 1945-51. [Abstract] [Full-text]
40. Variation in the PDE4D gene and ischemic stroke risk: a systematic review and meta-analysis on 5200 cases and 6600 controls.
    Stroke, 39(7): 1966-71. [Abstract] [Full-text]
41. Gene expression in peripheral blood differs after cardioembolic compared with large-vessel atherosclerotic stroke: biomarkers for the etiology of ischemic stroke.
    J Cereb Blood Flow Metab, 28(7): 1320-8. [Abstract] [Full-text]
42. Additive effects of statin and dipyridamole on cerebral blood flow and stroke protection.
    J Cereb Blood Flow Metab, 28(7): 1285-93. [Abstract] [Full-text]
43. Soluble epoxide hydrolase gene deletion is protective against experimental cerebral ischemia.
    Stroke, 39(7): 2073-8. [Abstract] [Full-text]
44. Cervical arterial dysfunction and manual therapy: a critical literature review to inform professional practice.
    Man Ther, 13(4): 278-88. [Abstract] [Full-text]
45. Association of apolipoprotein E genotype and cerebrovascular disease risk factors in a Turkish population.
    Int J Neurosci, 118(8): 1109-29. [Abstract] [Full-text]
46. How I interpreted the randomised trials of carotid angioplasty/stenting versus endarterectomy.
    Eur J Vasc Endovasc Surg, 36(1): 34-40. [Abstract] [Full-text]
47. Combined PET-FDG and USPIO-enhanced MR imaging in patients with symptomatic moderate carotid artery stenosis.
    Eur J Vasc Endovasc Surg, 36(1): 53-5. [Abstract] [Full-text]
48. Egr-1 regulates expression of the glial scar component phosphacan in astrocytes after experimental stroke.
    Am J Pathol, 173(1): 77-92. [Abstract] [Full-text]
49. Polymorphisms of the human platelet alloantigens HPA-1, HPA-2, HPA-3, and HPA-4 in ischemic stroke.
    Am J Hematol, 83(7): 570-3. [Abstract] [Full-text]
50. Racial disparities in the development of dysphagia after stroke: analysis of the California (MIRCal) and New York (SPARCS) inpatient databases.
    Arch Phys Med Rehabil, 89(7): 1358-65. [Abstract] [Full-text]
51. Validation of the Charlson Comorbidity Index for predicting functional outcome of stroke.
    Arch Phys Med Rehabil, 89(7): 1276-83. [Abstract] [Full-text]
52. A comparison of bilateral and unilateral upper-limb task training in early poststroke rehabilitation: a randomized controlled trial.
    Arch Phys Med Rehabil, 89(7): 1237-45. [Abstract] [Full-text]
53. Chronic atrial fibrillation: Incidence, prevalence, and prediction of stroke using the Congestive heart failure, Hypertension, Age >75, Diabetes mellitus, and prior Stroke or transient ischemic attack (CHADS2) risk stratification scheme.
    Am Heart J, 156(1): 57-64. [Abstract] [Full-text]

© 2004-2008 Stroke Research Today. All Rights Reserved.